Literature DB >> 24686066

Novel pneumocystis antigen discovery using fungal surface proteomics.

Mingquan Zheng1, Yang Cai, Taylor Eddens, David M Ricks, Jay K Kolls.   

Abstract

Pneumonia due to the fungus Pneumocystis jirovecii is a life-threatening infection that occurs in immunocompromised patients. The inability to culture the organism as well as the lack of an annotated genome has hindered antigen discovery that could be useful in developing novel vaccine- or antibody-based therapies as well as diagnostics for this infection. Here we report a novel method of surface proteomics analysis of Pneumocystis murina that reliably detected putative surface proteins that are conserved in Pneumocystis jirovecii. This technique identified novel CD4(+) T-cell epitopes as well as a novel B-cell epitope, Meu10, which encodes a glycosylphosphatidylinositol (GPI)-anchored protein thought to be involved in ascospore assembly. The described technique should facilitate the discovery of novel target proteins for diagnostics and therapeutics for Pneumocystis infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686066      PMCID: PMC4019171          DOI: 10.1128/IAI.01678-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

2.  The Pneumocystis Ace2 transcription factor regulates cell wall-remodeling genes and organism virulence.

Authors:  Theodore J Kottom; Andrew H Limper
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

3.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  The repair potential of a posterior composite material.

Authors:  A D Puckett; J W O'Hara; R Holder
Journal:  Miss Dent Assoc J       Date:  1986

5.  Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.

Authors:  Kerry M Empey; Melissa Hollifield; Kevin Schuer; Francis Gigliotti; Beth A Garvy
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Constantine G Haidaris; Terry W Wright; Allen G Harmsen
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Development of murine monoclonal antibodies to Pneumocystis carinii.

Authors:  F Gigliotti; D C Stokes; A B Cheatham; D S Davis; W T Hughes
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

8.  Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA.

Authors:  Jesse Wells; Francis Gigliotti; Patricia J Simpson-Haidaris; Constantine G Haidaris
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Elevated intracellular calcium triggers recruitment of the receptor cross-talk accessory protein calcyon to the plasma membrane.

Authors:  Mohammad Kutub Ali; Clare Bergson
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

10.  Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Authors:  Chad Steele; Luis Marrero; Steve Swain; Allen G Harmsen; Mingquan Zheng; Gordon D Brown; Siamon Gordon; Judd E Shellito; Jay K Kolls
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

2.  B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.

Authors:  Sanbao Ruan; Yang Cai; Alistair J Ramsay; David A Welsh; Karen Norris; Judd E Shellito
Journal:  Vaccine       Date:  2016-12-21       Impact factor: 3.641

3.  Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii.

Authors:  Beth A Garvy
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

Review 4.  Is the unique camouflage strategy of Pneumocystis associated with its particular niche within host lungs?

Authors:  Philippe M Hauser
Journal:  PLoS Pathog       Date:  2019-01-24       Impact factor: 6.823

5.  Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis.

Authors:  Taylor Eddens; Waleed Elsegeiny; David Ricks; Meagan Goodwin; William T Horne; Mingquan Zheng; Jay K Kolls
Journal:  mSphere       Date:  2019-09-04       Impact factor: 4.389

6.  Toward a humanized mouse model of Pneumocystis pneumonia.

Authors:  Guixiang Dai; Alanna Wanek; Taylor Eddens; Paul Volden; Jay K Kolls
Journal:  JCI Insight       Date:  2021-01-25

7.  Germline IgM predicts T cell immunity to Pneumocystis.

Authors:  Kristin Noell; Guixiang Dai; Dora Pungan; Anna Ebacher; Janet E McCombs; Samuel J Landry; Jay K Kolls
Journal:  JCI Insight       Date:  2022-09-08

8.  Pneumocystis and interactions with host immune receptors.

Authors:  Jennifer Claire Hoving
Journal:  PLoS Pathog       Date:  2018-02-22       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.